Background: This study aimed to translate and validate the Fear of Cancer Recurrence Inventory (FCRI) questionnaire into Persian and to investigate its psychometric properties.
Introduction
The number of cancer survivors has increased more than threefold over the last 30 years. Among patients with recently diagnosed cancer, nearly two- 1, 2 thirds are expected to survive five or more years. Psychosocial problems are common in cancer survivors. Fear of cancer recurrence (FCR) is one of these problems, which is estimated to involve 50-89% of cancer survivors. Two main definitions have been used for FCR: The first is defined as the "fear that cancer could return or progress in the same place 3 or in another part of the body" , which adopts a patient's perspective of FCR and is relevant across the cancer trajectory. The second is "the degree of concern about the chances of cancer returning at a future time"; this definition emphasizes recurrence 4,5 more than progression. These patients constantly express the need for help, which, unfortunately, is not addressed by cancer care systems, as reported by [6] [7] [8] [9] [10] [11] 20 to 40 percent of patients.
It is essential to screen for FCR using an appropriate measure. Several screening tools have been introduced in the literature, including subscales of more comprehensive psychosocial and quality-oflife assessment tools, brief FCR questionnaires, and 10 longer FCR instruments. Lack of a widely-accepted definition for FCR and the use of measures with different cut-off scores may explain an alternative approach for the assessment of FCR as well as 10, 11 variability in its reported prevalence rate.
Fear of Cancer Recurrence Inventory (FCRI) is a 42-item multidimensional questionnaire that is appropriate for all cancer patients. Items were developed based on a cognitive-behavioral 12 formulation of FCR , literature review, and DSM-IV diagnostic criteria. The FCRI was originally validated in a French-speaking sample of 600 patients with mixed cancers, and its English version 12 was developed later. The instrument had very good 12, 13 psychometric properties in previous studies.
To our knowledge, scanty research has been conducted in the Iranian population regarding the fear of cancer recurrence, which might be tracked to the lack of appropriate measures. The purpose of this study was to develop a valid and reliable version of FCRI in Persian.
Methods
The content validity and equivalence testing were performed by five independent academic psychiatrists and a clinical psychologist. They rated the degree of the content covered by each item of the instrument, which is supposed to measure as an index for content validity. A five-point Likert scale was used in the ascending order for "appropriateness"
The English version of FCRI was translated to Persian based on the standard guideline of the World 14 Health Organization (WHO). Accordingly, the English questionnaire was translated to Persian by two bilingual translators. After reaching a consensus regarding the translated Persian version, ten patients filled out the questionnaire, and words with unclear meaning were replaced and the final version was provided. An independent bilingual translator backtranslated the final Persian version to English.
Linguistic Validation
and "relevance" of the items.
Psychometric Evaluation Participants
Participants in this study were recruited from a breast cancer clinic affiliated to Tehran University of Medical Sciences (TUMS), and a private breast cancer clinic located in Tehran, Iran. Patients meeting the following criteria were included: The acceptable time period after the breast cancer treatment including surgery, radiation therapy and chemotherapy being six months to 5 years; absence of the objective evidence of recurrence; being fluent in the Persian language, and signing the informed consent. The protocol of the study was approved by the ethics committee of the Faculty of Medicine, Tehran University of Medical Sciences.
Measures

Fear of Cancer Recurrence Inventory (FCRI):
The English version of FCRI has 42 items. FCRI is a multidimensional inventory developed by Simard et al. for use in all cancer patients. The questionnaire was originally validated in French-speaking patients with different cancers, and the English version was developed later by the same authors. The inventory evaluates seven aspects associated with FCR: the potential stimuli activating FCR (triggers; sample item: "Conversations about cancer or illness in general"); the presence and severity of intrusive thoughts associated with FCR (severity; sample item: "I believe it is normal to be worried or anxious about the possibility of cancer recurrence"); the emotional disturbance associated with FCR (psychological distress; sample item: "When I think about the possibility of cancer recurrence, I feel frustration, anger or outrage"); the impact of FCR on important areas of functioning (functioning impairments; sample item: "My thoughts or fears about the possibility of cancer recurrence disrupt my work or everyday activities"); the self-criticism toward FCR intensity (insight; sample item: "I feel that I worry excessively about the possibility of cancer recurrence"); the behavioral reassurance such a s s e l f -e x a m i n a t i o n o r r e p e a t e d m e d i c a l consultations (reassurance; sample item: " I call my doctor or other health professional to reassure myself"); and other strategies to cope with FCR (coping strategies; sample item: "I pray, meditate or 13 do relaxation").
The Hospital Anxiety and Depression Scale (HADS): HADS is a brief and widely-used selfreport questionnaire to determine the levels of anxiety and depression a person experiences. It is a fourteen-item scale. It has two subscales: HADS-A for anxiety and HADS-D for depression. Seven of the items are related to anxiety and seven are related 15 to depression. It has been translated and validated in many languages and it is widely used in the Persian
Linguistic Validation
The Persian version of FCRI was developed 1 population for clinical and research purposes.
Statistical analyses
Results
Validity Study
Construct Validity:Factorial structure and dimensionality of the questionnaire were assessed through both principal component analysis (PCA) and confirmatory factor analysis (CFA).
Concurrent Validity:
In order to test the concurrent validity of the instrument, all participants completed the HADS questionnaire concurrent with the Persian version of FCRI, and the correlation of the scores of all questions was calculated.
Reliability Study
The Persian version of FCRI was tested for internal consistency through Cronbach's alpha coefficient for each domain and also for the whole questionnaire. A random sample of 60 patients was tested two weeks after the initial assessment. The intraclass correlation coefficient (ICC) was utilized for assessing the test-retest reliability of the questionnaire.
For determining the degree of agreement between expert panel members in the second step of the translation process, a content validity index (CVI) was calculated. To assess the reliability of the Persian version of FCRI, Chronbach's alpha coefficient was assessed for internal consistency. Chronbach's alpha of greater than 0.7 was assumed satisfactory. For testretest analysis, the intraclass correlation coefficient (ICC) was utilized. Principle component analysis (PCA) with oblique rotation was adopted for exploratory factor analysis. A Confirmatory factor analysis (CFA) with the parceling method was utilized as another way for assessing the 17 dimensionality of the questionnaire. Concurrent validity of FCRI was evaluated using correlations between the Persian version of FCRI subscale scores and HADS scores. A significance level of p ≤ .05 was assumed satisfactory. IBM SPSS-22 and AMOS-22 software were used for CFA.
A panel of experts examined content validity. The content validity index (CVI) for the seven subscales of the instrument (triggers, severity, psychological distress, functioning impairments, insight, reassurance and coping strategies) and total score of FCRI were 0.82, 0.84, 0.80, 0.85, 0.77, 0.79, 0.78 and 0.80 respectively. The Paucity of missing data in psychometric evaluation also confirmed the acceptability of the instrument.
based thoroughly on the previously-mentioned translation process. Each step was designed to improve the comprehensibility and acceptability of the questionnaire. There was no major cultural discrepancy between English and Persian versions.
Internal consistency was found to be acceptable with Cronbach's alpha coefficient at 0.86. The interclass correlation coefficient for test-retest reliability was between 0.87 and 0.99 (Table 3) .
A total of 450 patients with breast cancer participated in this study. The demographic characteristics of the subjects are summarized in Table 1 . The mean age of the patients was 50.50 years (SD=9.75). Regarding the marital status of participants, 9.1% were single, 78.8% were married, 6.1% were widowed, and 6.1% were divorced. The descriptive statistics of different measures are also presented in Table 2 . Table  4 , except for the domain of coping strategies, all other six domains of FCRI, HADS-A, and HADS-D subscales were well correlated.
Psychometric Evaluation
Concurrent validity of FCRI was measured by Pearson's correlation coefficient between FCRI domains and scores of HADS. As it is shown in
The principal component analysis revealed seven factors with eigenvalues of 13.96, 5.26, 2.33, 1.71, 1.53, 1.26, and 1.07, which accounted for 64.60 % of the variance observed (Figure 1 ). The factors extracted in this study were consistent with the domains of the original version of FCRI.
Validity Study
Based on the result of PCA, it is evident that the structure of the FCR could be explained better by a 7factor solution. Also, to address sample size limitation to run CFA with 42 items, we ran a CFA with the parceling method. For a good model fit in CFA, sample size plays a notable role in the analysis. It gains more significance when researchers propose a complex model with a greater number of indicators of a specific latent variable. The parceling method reduces the complexity of the proposed model by reducing the number of indicators. It has some advantages for CFA, including more reliability, meeting normality assumptions, satisfying sample 18, 19 size requirements, and better model fit indices. In the parceling method, after computing item-scale correlation coefficients, two or three items would be summed creating a group under their subscale. Then, CFA would be run on these created groups rather than original items of the scale. The path diagram of CFA is presented in Figure 2 . The goodness of fit measures is shown in Table 5 for CFA with 42 items and parceling methods. As illustrated in table 5, the goodness of fit measures was better in the parceling model than the original 42-item model. In the parceling model, RMSEA, CFI, IFI, PNFI, and PCFI showed acceptable goodness of fit, and GFI was nearly close to the acceptable value, i.e. 0.90. Meyers et al discussed the detailed information on the target 20 values. As previously mentioned, the parceling According to figure 2, the factor coefficients of the original hypothesized model (with 42 items) were assessed by AMOS 22 and the maximum likelihood estimation method. All of the factor coefficients were statistically significant at p<0.05. The standardized regression weights (β) of the Item-Subscale level for the 7-factor solution changed from 0.21 (item 8-Triggers) to 0.89 (item 19-Distress). The standardized regression weights of the Subscale-method can help researchers to reduce the complexity of the model and address sample size limitation. Then, the results of the parceling model might imply that the sample size limitation in the present study leads to weaker model fit indices in CFA and there is no need to modify the hypothesized model of FCR.
FCR total Score level ranged from 0.14 (Coping) to 0.95 (Severity). The majority of standardized regression weights achieved meaningful significance (β> 0.3). However, two Beta weights did not achieve meaningful significance criterion, including item 8 (0.21) and the Coping subscale (0.14). Then, it might be proposed to modify the hypothesized model to achieve a stronger model for the FCR. It is also notable to mention that the Beta weight of the subscale level in the parceling model ranged from 0.21 (coping) to 0.95 (severity). The Beta weight of the coping subscale increased from 0.14 to 0.21, respectively, in original and parceling models. It might be considered that sample size limitation could explain the weak results of the original model. Factor analysis using principal component analysis (PCA) revealed seven-factor solutions for this questionnaire. This finding is similar to seven dimensions of the original French questionnaire and 13, 14 the English version of FCRI. Confirmatory factor analysis, along with parceling method, illustrated an acceptable fit of the factor structure of the FCR. However, the sample size limitation could explain the weak goodness of fit measures for CFA with 42 items.
The current study has various limitations that should be considered in the interpretation of the results. First, the sample size of the study may not be ideal for confirmatory factor analysis. Second, due to the lack of another validated instrument for the evaluation of FCR, only the HADS questionnaire was used for the assessment of concurrent validity of the Persian version of FCRI.
A similar value was found by Lebel et al. while assessing 350 English-speaking patients with different cancer types. In that study, the English version had high internal consistency (0.96 for the total scale and 0.71-0.94 for the subscales) and testretest reliability (0.88 for the total scale and 13 0.56-0.87 for the subscales). In the original study conducted by Simard et al., they evaluated 600 French-Canadian patients who had been survivors of breast, prostate, lung, and colorectal cancer. Results supported the internal consistency (á=0.95) and the temporal stability (r=0.89) of FCRI, as well as its construct validity with other self-report scales assessing the fear of cancer recurrence (r=0.68 to 0.77) or related constructs such as psychological distress (r=0.43 to 0.77), and quality of life (r= 0.20 12 to 0.36).
This study aimed to develop a Persian version of FCRI and to assess its reliability and validity. It was accomplished through standard forward-backward guidelines. The final version of the questionnaire was obtained after face and content validation. The FCRI was comprehensible and easily applicable to the patients. Content validity indices of total and specific domains of the questionnaire were robust. According to Lynn, with six or more judges, the CVI should not be lower than 0.78 for an item to be judged 21 acceptable. The Cronbach's alpha for the whole questionnaire that provides an estimate of internal reliability was 0.86, which is high and satisfactory. Test-retest reliability was 0.96 over two weeks using ICC, which shows the high stability of FCRI over time. Correlations between the FCRI and HADS were remarkable (r= 0.252 to 0.639), indicating acceptable concurrent validity. As expected, there was a negative correlation between HADS subscale score and coping strategies subscale score of FCRI. In other words, higher scores in coping strategies imply the fact that patients have better ways to deal with their fear of cancer recurrence and the lower possibility of depression and anxiety. 
